BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 35443626)

  • 41. Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders.
    Truong TTT; Panizzutti B; Kim JH; Walder K
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug Repurposing Using Deep Embeddings of Gene Expression Profiles.
    Donner Y; Kazmierczak S; Fortney K
    Mol Pharm; 2018 Oct; 15(10):4314-4325. PubMed ID: 30001141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Machine Learning Applications in Drug Repurposing.
    Yang F; Zhang Q; Ji X; Zhang Y; Li W; Peng S; Xue F
    Interdiscip Sci; 2022 Mar; 14(1):15-21. PubMed ID: 35066811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Considerations and challenges for sex-aware drug repurposing.
    Fisher JL; Jones EF; Flanary VL; Williams AS; Ramsey EJ; Lasseigne BN
    Biol Sex Differ; 2022 Mar; 13(1):13. PubMed ID: 35337371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Next-generation drug repurposing using human genetics and network biology.
    Nabirotchkin S; Peluffo AE; Rinaudo P; Yu J; Hajj R; Cohen D
    Curr Opin Pharmacol; 2020 Apr; 51():78-92. PubMed ID: 31982325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
    Jain P; Jain SK; Jain M
    Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications.
    He H; Duo H; Hao Y; Zhang X; Zhou X; Zeng Y; Li Y; Li B
    Comput Biol Med; 2023 Mar; 155():106671. PubMed ID: 36805225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Drug-Target Network-Based Supervised Machine Learning Repurposing Method Allowing the Use of Multiple Heterogeneous Information Sources.
    Nascimento ACA; PrudĂȘncio RBC; Costa IG
    Methods Mol Biol; 2019; 1903():281-289. PubMed ID: 30547449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
    Le DH; Nguyen-Ngoc D
    Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Innovative target mining stratagems to navigate drug repurposing endeavours.
    Saravanan KS; Satish KS; Saraswathy GR; Kuri U; Vastrad SJ; Giri R; Dsouza PL; Kumar AP; Nair G
    Prog Mol Biol Transl Sci; 2024; 205():303-355. PubMed ID: 38789185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. REPRODUCIBLE DRUG REPURPOSING: WHEN SIMILARITY DOES NOT SUFFICE.
    Guney E
    Pac Symp Biocomput; 2017; 22():132-143. PubMed ID: 27896969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Computational Bipartite Graph-Based Drug Repurposing Method.
    Zheng S; Ma H; Wang J; Li J
    Methods Mol Biol; 2019; 1903():115-127. PubMed ID: 30547439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integration of various protein similarities using random forest technique to infer augmented drug-protein matrix for enhancing drug-disease association prediction.
    Kitsiranuwat S; Suratanee A; Plaimas K
    Sci Prog; 2022; 105(3):368504221109215. PubMed ID: 35801312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computational Drug Repurposing Based on a Recommendation System and Drug-Drug Functional Pathway Similarity.
    Shao M; Jiang L; Meng Z; Xu J
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Analytical Review of Computational Drug Repurposing.
    Sadeghi SS; Keyvanpour MR
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):472-488. PubMed ID: 31403439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug repositioning using drug-disease vectors based on an integrated network.
    Lee T; Yoon Y
    BMC Bioinformatics; 2018 Nov; 19(1):446. PubMed ID: 30463505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computational Methods for Drug Repurposing.
    Rapicavoli RV; Alaimo S; Ferro A; Pulvirenti A
    Adv Exp Med Biol; 2022; 1361():119-141. PubMed ID: 35230686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug Repurposing Prediction for Immune-Mediated Cutaneous Diseases using a Word-Embedding-Based Machine Learning Approach.
    Patrick MT; Raja K; Miller K; Sotzen J; Gudjonsson JE; Elder JT; Tsoi LC
    J Invest Dermatol; 2019 Mar; 139(3):683-691. PubMed ID: 30342048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
    Alaimo S; Pulvirenti A
    Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.